FLUDARABINE PLUS TREOSULFAN OR TBI AS A CONDITIONING THERAPY BEFORE ALLOGENEIC HSCT IN ACUTE LYMPHOBLASTIC LEUKEMIA. A MATCHED-PAIR ANALYSIS FROM THE ALWP OF THE EBMT

Abstract

[No abstract available]